HUTCHMED (China) (HMDCF) Gross Margin (2015 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly Gross Margin came in at 101.23% in Q1 2021, down 1005.0% year-over-year from 11.19% in Q1 2020, and up 219.77% quarter-over-quarter from 84.52% in Q2 2020.
Powered by 
Analysis
HUTCHMED (China) (HMDCF) Gross Margin (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Gross Margin for 6 consecutive years, with 101.23% the latest figure, recorded in Q1 2021.
- On a quarterly basis, Gross Margin fell 1005.0% year-over-year to 101.23% in Q1 2021; TTM through Mar 2021 was 7.32%, a 2587.0% decrease from a year earlier, with the FY2025 full-year figure at 93.38%, up 110.0% from the prior year.
- Gross Margin was 101.23% for Q1 2021 at HUTCHMED (China), up from 84.52% in the prior quarter.
- Over five years, Gross Margin peaked at 275.39% in Q3 2019 and troughed at 208.06% in Q4 2019.
- A 4-year average of 51.45% and a median of 92.32% in 2018 frame the typical range for Gross Margin.
- The widest YoY moves for Gross Margin: up 18264 bps in 2019, down 30038 bps in 2019.
- Over 4 years, Gross Margin stood at 92.32% in 2018, then slumped by 325 bps to 208.06% in 2019, then soared by 59 bps to 84.52% in 2020, then surged by 220 bps to 101.23% in 2021.
- The last three Gross Margin figures came in at 101.23% (Q1 2021), 84.52% (Q2 2020), and 111.28% (Q1 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.50 Bn | 197.51 Bn | 7.24 Bn | 72.04% |
| 2 | Gilead Sciences | 181.29 Bn | 178.11 Bn | 6.22 Bn | 79.76% |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 85.33% |
| 4 | Regeneron Pharmaceuticals | 82.55 Bn | 74.56 Bn | 3.93 Bn | 91.59% |
| 5 | Argenx Se | 61.65 Bn | 56.47 Bn | 1.37 Bn | 90.43% |
| 6 | Moderna | 54.65 Bn | 49.52 Bn | 52.00 Mn | 35.86% |
| 7 | Alnylam Pharmaceuticals | 34.18 Bn | 30.87 Bn | 992.69 Mn | 76.90% |
| 8 | Biogen | 31.36 Bn | 30.07 Bn | 1.96 Bn | 71.60% |
| 9 | Roivant Sciences | 30.01 Bn | 30.01 Bn | 1.16 Mn | 80.31% |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 101.23% |
| Jun 30, 2020 | -84.52% |
| Mar 31, 2020 | 111.28% |
| Dec 31, 2019 | -208.06% |
| Sep 30, 2019 | 275.39% |
| Jun 30, 2019 | -88.75% |
| Mar 31, 2019 | 92.74% |
| Dec 31, 2018 | 92.32% |
| Sep 30, 2018 | 92.75% |
| Jun 30, 2018 | 90.42% |
| Mar 31, 2018 | 91.18% |
| Jun 30, 2016 | 71.54% |
| Jun 30, 2015 | 59.24% |